OMLONTI Trademark

Trademark Overview


On Monday, November 13, 2017, a trademark application was filed for OMLONTI with the United States Patent and Trademark Office. The USPTO has given the OMLONTI trademark a serial number of 79227958. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, September 10, 2025. This trademark is owned by Santen Pharmaceutical Co., Ltd.. The OMLONTI trademark is filed in the Pharmaceutical Products category with the following description:

Collyrium; eye drops; ophthalmological preparations; [ pharmaceutical preparations for treatment of cataracts; ] pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; [ ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; ] pharmaceutical preparations for the treatment of eye diseases and conditions [; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules s...
omlonti

General Information


Serial Number79227958
Word MarkOMLONTI
Filing DateMonday, November 13, 2017
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, September 10, 2025
Registration Number5640040
Registration DateTuesday, January 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements


Goods and ServicesCollyrium; eye drops; ophthalmological preparations; [ pharmaceutical preparations for treatment of cataracts; ] pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; [ ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; ] pharmaceutical preparations for the treatment of eye diseases and conditions [; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton, namely, cotton for medical purposes, cotton sticks for medical purposes and antiseptic cotton; adhesive plasters, namely, adhesive plasters for medical purposes, sticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandages, namely, antiseptic liquid bandages, liquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; cotton sticks for medical purposes; incontinence diapers; diapers; diaper covers, namely, inserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, infant formula and meal replacement beverages for babies adapted for medical use; food for babies; dietary supplements for animals ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanten Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka-shi Osaka 530-8552
JP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Tuesday, March 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Saturday, March 10, 2018APPLICATION FILING RECEIPT MAILED
Thursday, March 1, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, March 20, 2018REFUSAL PROCESSED BY MPU
Monday, September 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 13, 2018NON-FINAL ACTION WRITTEN
Wednesday, March 14, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 20, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 6, 2018REFUSAL PROCESSED BY IB
Wednesday, August 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 30, 2018ASSIGNED TO LIE
Thursday, September 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 12, 2018NOTIFICATION PROCESSED BY IB
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 1, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 17, 2019FINAL DISPOSITION PROCESSED
Wednesday, April 17, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 26, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 26, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 1, 2019REGISTERED-PRINCIPAL REGISTER
Friday, May 3, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 10, 2025REGISTERED-SEC.71 ACCEPTED
Wednesday, September 10, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, May 1, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, January 1, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, June 4, 2025TEAS SECTION 71 RECEIVED